By DENISE GRADY

The panel voted unanimously to recommend that the agency approve a treatment that genetically alters a patient’s own cells to fight leukemia.

Published: July 11, 2017 at 05:00PM

from NYT Health https://www.nytimes.com/2017/07/12/health/fda-novartis-leukemia-gene-medicine.html?partner=IFTTT
via IFTTT

YOUR AD HERE UPDATED